# Mereo BioPharma Group plc: Form 6-K, filed Dec 18, 2023

- Company: [Mereo BioPharma Group plc](/companies/mreo.md) (CIK 1719714)
- Form: 6-K
- Filed: 2023-12-18
- Accepted by EDGAR: Dec 18, 2023, 16:10 ET
- Period: 2023-12-18
- Accession: 0001193125-23-297624
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1719714/000119312523297624/d677335d6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719714/000119312523297624/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719714/000119312523297624/d677335d6k.htm

Filed Dec 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-297624. Last ingested by Listed: Nov 9, 2026, 18:01 ET. No prices; not investment advice.